Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
Patel
Parag
P
Patel
Paraj
P
Gonzalez
Rafael
R
Gonzales
Rafael
R
Dokainish
Hisham
H
Lakkis
Nasser
N
D000244:Adenosine Diphosphate / Q000008:administration & dosage / Q000494:pharmacology*; D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D002951:Citrates / Q000494:pharmacology; D000077144:Clopidogrel; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D000077559:Sodium Citrate; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000590:Amino Acid Chloromethyl Ketones; D002614:Chelating Agents; D002951:Citrates; D015853:Cysteine Proteinase Inhibitors; D010975:Platelet Aggregation Inhibitors; D000077559:Sodium Citrate; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; C040308:phenylalanyl-prolyl-arginine-chloromethyl ketone; D013988:Ticlopidine